| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000009900 |
| Receipt No. | R000011595 |
| Official scientific title of the study | Effects of droperidol on postoperative abnormal behaviors in children undergoing general anesthesia: Systematic review and meta-analysis of randomized controlled trials. |
| Date of disclosure of the study information | 2013/02/01 |
| Last modified on | 2016/08/03 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | Effects of droperidol on postoperative abnormal behaviors in children undergoing general anesthesia: Systematic review and meta-analysis of randomized controlled trials. | |
| Title of the study (Brief title) | Effects of droperidol on postoperative abnormal behaviors in children undergoing general anesthesia: Systematic review and meta-analysis of randomized controlled trials. | |
| Region |
|
|
| Condition | ||
| Condition | postoperative abnormal behaviors such as agitation or restless in children undergoing general anesthesia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effects of droperidol on postoperative abnormal behaviors such as agitation or restless in children undergoing general anesthesia. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The primary outcomes of this present meta-analysis are the incidence of postoperative abnormal behaviors such as agitation, restless, or extrapyramidal symptoms. |
| Key secondary outcomes | The secondary outcomes are the incidence of sedation. |
| Base | |
| Study type | Others,meta-analysis etc |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All randomized controlled trials comparing droperidol with any comparator (i.e., placebo, any drugs, or no treatment) administered during or before general anesthesia in children are included in this study. Eligibility is not restricted by language, type of surgery, or anesthetic technique. | |||
| Key exclusion criteria | We exclude studies which did not report our primary or secondary outcomes (i.e., postoperative abnormal behaviors such as agitation or restless, extrapyramidal symptoms, or sedation). We exclude studies which did not compare droperidol with any comparator (e.g., droperidol and midazolam vs. fentanyl), whereas we include studies "droperidol and drug A vs. drug A" because we can count the study as "droperidol vs. placebo". We also exclude data from abstracts, posters, case reports, comments or letters to the editor, reviews, and animal studies. | |||
| Target sample size | 0 | |||
| Research contact person | |
| Name of lead principal investigator | Takahiro Mihara |
| Organization | Yokohama City University Graduate School of Medicine |
| Division name | Department of Anesthesiology and Critical Care Medicine |
| Address | 3-9 Fukuura, Kanazawa-ku, Yokohama, Japan |
| TEL | 045-787-2918 |
| miharaxxxtotoro@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Takahiro Mihara |
| Organization | Yokohama City University Graduate School of Medicine |
| Division name | Department of Anesthesiology and Critical Care Medicine |
| Address | 2-138-4 Mutsukawa, Minami-ku, Yokohama 232-8555, Japan |
| TEL | 045-711-2351 |
| Homepage URL | |
| miharaxxxtotoro@yaoo.co.jp | |
| Sponsor | |
| Institute | Department of Anesthesiology and Critical Care Medicine, Yokohama City University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Design and search strategy
We search MEDLINE, CENTRAL, Embase, Web of Science, and ClinicalTrials.gov. up to February 1, 2013. In addition, the reference lists of the retrieved full articles are searched. Two authors independently scan the titles and abstracts of reports. If eligibility can not be determined from the title or abstract, the full paper is retrieved. Potentially relevant studies, chosen by at least one author, are retrieved and evaluated in full-text versions. The articles that met the inclusion criteria are assessed separately by two authors, and any discrepancies are resolved through discussion. Data abstraction A data collection sheet is created and include data on: (i) ASA-Physical Status, (ii) age, (iii) type of surgery, (iv) type of anesthesia, (v) route of administration of droperidol, (vi) timing of administration, (vii) dose of droperidol, (viii) type of control, (ix) number of incidence of PONV, number of incidence of postoperative abnormal behaviors such as (x) emergence agitation, (xi) other abnormal behaviors (e.g., restless), (xii) number of incidence of extrapyramidal symptoms, (xiii) number of incidence of sedation or (xiv) sedation time if reported, and (xv) primary outcome of the study. When abnormal behaviors were classified according to severity, we abstract the data of the number of incidence of abnormal behaviors from the most severe category. When multiple control groups including placebo group were made in individual studies, we choice the placebo group as a comparator group in this meta-analysis. Two authors extract the data independently from the studies included and then cross-check the data. Risk of bias assessment We assess the risk of bias as described by the Cochrane Handbook for Systematic Reviews of Interventions. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000011595 |